1. "Department of Pathology and Laboratory Medicine"
Formats
  1. Journal Article (6438)
  2. Meeting Abstract (5172)
  3. Review (332)
  4. Book Section (310)
  5. Editorial (92)
  6. Research Letter (73)
  7. Guidelines (52)
  8. Correspondence (47)
  9. Conference Paper (38)
  10. Miscellaneous (37)
  11. Book Whole (24)
Groups
  1. Department of Pathology and Laboratory Medicine (12615)
  2. GSK Faculty (4773)
  3. Department of Medicine (4722)
  4. Surgery (3639)
  5. Solid Tumor Oncology Division (3422)
  6. Human Oncology and Pathogenesis Program (3037)

More Groups

People
  1. Marc Ladanyi (1327)
  2. Victor Reuter (1228)
  3. Cristina Antonescu (895)
  4. Michael Berger (765)
  5. William Travis (743)
  6. Jinru Shia (719)

More People

Years
  1. 2025 (307)
  2. 2024 (719)
  3. 2023 (766)
  4. 2022 (841)
  5. 2021 (677)
  6. 2020 (787)

More Years

Publications
  1. Laboratory Investigation (1448)
  2. Modern Pathology (1440)
  3. Journal of Clinical Oncology (863)
  4. American Journal of Surgical Pathology (429)
  5. Cancer Research (426)
  6. Blood (349)

More Publications

Publishers
  1. Nature Publishing Group (1939)
  2. Nature Research (1457)
  3. Elsevier Inc. (1139)
  4. American Society of Clinical Oncology (955)
  5. American Association for Cancer Research (923)
  6. Lippincott Williams & Wilkins (896)

More Publishers

Results (12615)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Routine use of cfDNA isolated from nail clippings as a source of matched non-tumor DNA for genetic studies in hematologic malignancies
    Meeting Abstract

    Krystel-Whittemore, M.; Arcila, M.; Vanderbilt, C.; Ptashkin, R.; Nafa, K.
    Journal of Molecular Diagnostics (2022)

    Fulltext@MSK | Save
  • Somatic synonymous variants (silent mutations) are highly enriched in hypermethylated or hypomethylated CPG sites compared to missense variants
    Meeting Abstract

    Dermawan, J.; Villafania, L.; Benhamida, J.; Ladanyi, M.; Vanderbilt, C.
    Journal of Molecular Diagnostics (2022)

    Fulltext@MSK | Save
  • NGS-based chimerism analysis challenges and solutions: Donor cell contamination in post-transplant buccal swabs
    Meeting Abstract

    Blouin, A. G.; Askar, M.; Ye, F.; Nelson, W.; Geraghty, D.
    Human Immunology (2022)

    Fulltext@MSK | Save
  • Molecular and pathologic data can guide selection of endometrioid endometrial cancer patients for ovarian preservation
    Meeting Abstract

    Manning-Geist, B.; Rios-Doria, E.; Liu, Y.; Ellenson, L.; Zhou, Q.; Leitao, M.; Abu-Rustum, N.; Weigelt, B.; Mueller, J.
    Gynecologic Oncology (2022)

    Fulltext@MSK | Save
  • Prognosis of isolated tumor cells and the utility of molecular classification in early stage endometrioid endometrial cancer
    Meeting Abstract

    Rios-Doria, E.; Abu-Rustum, N.; Alektiar, K.; Makker, V.; Liu, Y.; Zamarin, D.; Friedman, C.; Aghajanian, C.; Ellenson, L.; Weigelt, B.; more...
    Gynecologic Oncology (2022)

    Fulltext@MSK | Save
  • Sentinel lymph node mapping in patients with endometrial hyperplasia: A practice to preserve or abandon?
    Meeting Abstract

    Mueller, J.; Rios-Doria, E.; Park, K.; Broach, V.; Jewell, E.; Zivanovic, O.; Sonoda, Y.; Abu-Rustum, N.; Leitao, M.; Gardner, G.
    Gynecologic Oncology (2022)

    Fulltext@MSK | Save
  • Molecular classification of endometrial carcinomas: A single-institution review
    Meeting Abstract

    Rios-Doria, E.; Abu-Rustum, N.; Leitao, M.; Alektiar, K.; Makker, V.; Liu, Y.; Zamarin, D.; Friedman, C.; Aghajanian, C.; Ellenson, L.; more...
    Gynecologic Oncology (2022)

    Fulltext@MSK | Save
  • Safety and immunogenicity of anti PD-L1 (atezolizumab) given as an immune primer or concurrently with extended field chemoradiotherapy for node positive locally advanced cervical cancer: An NRG oncology trial
    Meeting Abstract

    Mayadev, J.; Zamarin, D.; Deng, W.; Lankes, H.; Pesci, G.; Park, K.; Banbury, B.; Sherry, N.; Ghamande, S.; Holman, L.; more...
    Gynecologic Oncology (2022)

    Fulltext@MSK | Save
  • Risk stratification of stage I grade 3 endometrioid endometrial carcinoma
    Meeting Abstract

    Zammarrelli, W.; Kim, S.; Paula, A. D. C.; Rios-Doria, E.; Zhou, Q.; Alektiar, K.; Aghajanian, C.; Makker, V.; Leitao, M.; Abu-Rustum, N.; more...
    Gynecologic Oncology (2022)

    Fulltext@MSK | Save
  • Ensuring remote diagnostics for pathologists: An open letter to the US Congress
    Correspondence

    Lennerz, J. K.; Pantanowitz, L.; Amin, M. B.; Eltoum, I. E.; Hameed, M. R.; Kalof, A. N.; Khanafshar, E.; Kunju, L. P.; Lazenby, A. J.; Montone, K. T.; more...
    Nature Medicine (2022)

    Fulltext@MSK | Save